Phase 1 NF1 Mutation Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas

NF1 Mutation

Pasithea Therapeutics Corp.56 enrolled5 locationsNCT06961565

Recruiting

Phase 1

PAS-004 in Patients With Advanced Solid Tumors

Advanced Solid TumorsRAS MutationNF1 Mutation+1 more

Pasithea Therapeutics Corp.48 enrolled7 locationsNCT06299839